PMID: 237402Jan 1, 1975Paper

Pharmacokinetics and biopharmaceutics of some adrenergic beta-receptor antagonists with special emphasis on alprenolol and metoprolol

Acta Pharmacologica Et Toxicologica
C G Regardh

Abstract

No abstract listed.

References

Feb 1, 1973·Life Sciences. Pt. 1: Physiology and Pharmacology·B AbladL Ek
Apr 21, 1973·British Medical Journal·S G CarruthersM J Walsh
Mar 1, 1973·The Journal of Pharmacy and Pharmacology·D PerrierR N Boyes
Jan 12, 1974·British Medical Journal·G S StokesI R Thornell
Jul 26, 1974·European Journal of Clinical Pharmacology·C R Kumana, C M Kaye
Jan 1, 1968·Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie·A M BarrettL H Smith
Sep 26, 1970·British Medical Journal·D J Coltart, D G Shand
Sep 1, 1971·British Journal of Pharmacology·J D Fitzgerald, S R O'Donnell
Mar 1, 1972·Clinical Pharmacology and Therapeutics·C R Cleaveland, D G Shand
Sep 1, 1972·Clinical Pharmacology and Therapeutics·D W SchneckW R Wilson
Jan 1, 1973·Clinical Pharmacology and Therapeutics·G Bodem, C A Chidsey
Aug 23, 1974·European Journal of Clinical Pharmacology·M D RawlinsF Sjöqvist
Oct 1, 1974·Acta Pharmacologica Et Toxicologica·N O BodinR Svensson
Sep 1, 1974·Clinical Pharmacology and Therapeutics·H SundquistM Arstila
Mar 1, 1972·European Journal of Clinical Pharmacology·C F GeorgeC T Dollery
Apr 1, 1973·Journal of Pharmacokinetics and Biopharmaceutics·M RowlandG G Graham
May 1, 1974·Clinical Pharmacology and Therapeutics·S G CarruthersR G Shanks
Jan 1, 1974·European Journal of Clinical Pharmacology·R GuglerH J Dengler
Jan 1, 1974·European Journal of Clinical Pharmacology·E E OhnhausF Kalberer
Jan 1, 1972·Journal of Pharmaceutical Sciences·M Rowland
May 20, 1972·British Medical Journal·F D ThompsonD M Foulkes
Oct 1, 1969·Diabetologia·S P AllisonR A Saunders
Jan 1, 1970·Clinical Pharmacology and Therapeutics·D G ShandJ A Oates
Sep 1, 1971·Clinical Pharmacology and Therapeutics·M GibaldiH Weintraub
Jan 1, 1969·Clinical Pharmacology and Therapeutics·R NagashimaG Levy
Jan 1, 1969·Journal of Pharmaceutical Sciences·P A Harris, S Riegelman
Sep 1, 1966·The American Journal of Cardiology·R S McNeill, C G Ingram
May 1, 1966·Clinical Pharmacology and Therapeutics·G Levy
Nov 1, 1967·Life Sciences·A M LandsH J Buzzo
Jun 1, 1948·The American Journal of Physiology·R P AHLQUIST

Citations

Dec 18, 1978·European Journal of Clinical Pharmacology·O F ElseI R Edwards
Jan 1, 1981·European Journal of Clinical Pharmacology·O AnderssonJ Thomis
Jun 1, 1977·British Journal of Clinical Pharmacology·J Meier, E Nüesch

Related Concepts

Adrenergic beta-Antagonists
Alprenolol Hydrochloride
Biopharmaceutics
Metabolic Biotransformation
Diastolic Blood Pressure
Half-Life
Pulse Rate
Kidney
Diphenyl Oxides
Propanolamines

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Generating Insulin-Secreting Cells

Reprogramming cells or using induced pluripotent stem cells to generate insulin-secreting cells has significant therapeutic implications for diabetics. Here is the latest research on generation of insulin-secreting cells.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.

Epigenome Editing

Epigenome editing is the directed modification of epigenetic marks on chromatin at specified loci. This tool has many applications in research as well as in the clinic. Find the latest research on epigenome editing here.